Recent Finacing
Recent Raise
Nura Bio is a clinical-stage biopharmaceutical company developing brain-penetrant SARM1 inhibitors and a multi-target preclinical pipeline of small-molecule neuroprotectants that halt axon degeneration and modulate microglial responses.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
